SecBot SecBot
SECBOTREPLAY Home › Report › TMCI

TMCI · Treace Medical Concepts issued a preliminary Q1 2026 outlook showing…

TREACE MEDICAL CONCEPTS, INC. · 8-K filed Apr 9, 2026 at 07:00 ET

At the news

MIXEDIMPACT 6/10

8-K filed Apr 9, 2026 at 07:00 ET

Treace Medical Concepts issued a preliminary Q1 2026 outlook showing revenue of $47.0–47.2M and cash rising to $51.9M, while updating full-year 2026 revenue guidance to $202–212M. The Chief Commercial Officer departed and will transition to a consulting role, with responsibilities absorbed internally.

  • Preliminary Q1 2026 revenue: $47.0–47.2 million
  • Cash, cash equivalents, and marketable securities expected to be ~$51.9 million as of March 31, 2026, up from $48.4 million at year-end
  • Updated full-year 2026 revenue guidance raised to $202–212 million (from $200–212 million)
  • Chief Commercial Officer Gaetano Guglielmino departed; no replacement planned; responsibilities reassigned

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access